Showing all 11 results
-
BRAFTOVI
BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) are prescription medicines used together to treat people with a type of skin cancer called […]
Read more -
ENHERTU
ENHERTU is FDA-approved for the treatment of several types of cancer ENHERTU is a prescription medicine used to treat adults […]
Read more -
IDHIFA
IDHIFA® (enasidenib) is indicated for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with […]
Read more -
MEKINIST
Mekinist is a cancer medicine used to treat adults whose cancer cells have a specific genetic mutation (change) in their […]
Read more -
PAXLOVID
The FDA has authorized the emergency use of PAXLOVID, an investigational medicine, for the treatment of mild-to-moderate COVID-19 in adults […]
Read more -
PEMAZYRE
Ask Your Oncologist About PEMAZYRE PEMAZYRE is the first FDA-approved prescription medicine that is used to treat adults with bile duct cancer (cholangiocarcinoma) that […]
Read more -
QINLOCK
QINLOCK is a prescription medicine used to treat adults with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more […]
Read more -
STIVARGA
STIVARGA is indicated for patients with a type of liver cancer called hepatocellular carcinoma in people who have been previously treated […]
Read more -
TABRECTA
TABRECTA is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation […]
Read more -
TRODELVY (for Breast Cancer)
Trodelvy is a cancer medicine used to treat adults with a type of breast cancer known as triple-negative breast cancer. […]
Read more -
TUKYSA (tucatinib)
TUKYSA (tucatinib), along with trastuzumab and capecitabine, is a targeted oral treatment option. It’s for people with HER2+ metastatic breast […]
Read more